Skip to main contentAI and Advanced
/
NEPHROPLUS · NSEBSE SENSEX76,132.81-0.50%BSE |
NIFTY 5023,779.15-0.50%NSE |
NIFTY BANK57,088.3-0.49%NSE |
NIFTY IT29,995.2-2.28%NSE |
NIFTY AUTO27,698.75-0.04%NSE |
NIFTY FMCG45,592.15-0.66%NSE |
NIFTY PHARMA26,675.5+0.75%NSE |
NIFTY 50023,156.2-0.42%NSE |
NE
NSE · Equity shares · Healthcare Facilities15.95 · 2.29%
Nephrocare Health Services NEPHROPLUS
NSE:INR 713
BSE:INR 714
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for NEPHROPLUS
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 697.05
Day rangeINR 697.55 — INR 715.7
52-week rangeINR 445 — INR 769.75
Volume1.89 L
Market cap6,933.5
P/E87.61
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)998.85
Net Income (INR Cr)76.84
P/E Ratio87.61
EPS8.31
Research path: Interpret Nephrocare Health Services's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
NEPHROPLUSNephrocare Health Services1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,470.87 | 996.46 | 806.02 |
| Accumulated Depreciation Total | -311.03 | -275.87 | -204.76 |
| Cash Equivalents | 34.23 | 23.78 | 34.64 |
| Other Liabilities Total | 6.29 | 5.54 | 7.34 |
| Accrued Expenses | 23.6 | 6.38 | 7.01 |
| Long Term Debt | 0.05 | 96 | 123.24 |
| Common Stock Total | 20.07 | 1.77 | 1.75 |
| Other Equity Total | 8.49 | -10.09 | -9.84 |
| Other Current Assets Total | 33.96 | 28.42 | 3.22 |
| Prepaid Expenses | 4.62 | 4.54 | 3.74 |
| Total Assets | 1,470.87 | 996.46 | 806.02 |
| Current Portof LT Debt/Capital Leases | 21.36 | 35.79 | 32.82 |
| Additional Paid-In Capital | 1,022.45 | 606.58 | 508.7 |
| Cash | 89.66 | 102.04 | 26.51 |
| Total Equity | 1,116.49 | 584.11 | 413.71 |
| Long Term Investments | 42.39 | 14.1 | 16.1 |
| Retained Earnings(Accumulated Deficit) | 65.48 | -17.8 | -90.29 |
| Total Common Shares Outstanding | 10.03 | 10.03 | 10.03 |
| Property/Plant/Equipment Total-Gross | 712.76 | 605.76 | 509.36 |
| Tangible Book Valueper Share Common Eq | 99.26 | 50.65 | 35.72 |
| Goodwill Net | 86.69 | 55.51 | 40.95 |
| Total Liabilities | 354.37 | 412.35 | 392.31 |
| Total Debt | 79.71 | 257.78 | 267.84 |
| Short Term Investments | 302.37 | 82.46 | 84.2 |
| Cashand Short Term Investments | 426.26 | 208.28 | 145.35 |
| Total Receivables Net | 328.91 | 270.7 | 205.14 |
| Notes Payable/Short Term Debt | 13.23 | 101.11 | 93.01 |
| Deferred Income Tax | 3.55 | 2.04 | 0.37 |
| Accounts Receivable-Trade Net | 317.41 | 266.42 | 202.67 |
| Property/Plant/Equipment Total-Net | 401.73 | 329.89 | 304.59 |
| Total Current Liabilities | 299.41 | 283.9 | 242.58 |
| Total Inventory | 45.42 | 33.42 | 32.6 |
| Accounts Payable | 143.01 | 112.88 | 70.53 |
| Other Currentliabilities Total | 98.22 | 27.73 | 39.22 |
| Total Long Term Debt | 45.12 | 120.87 | 142.02 |
| Intangibles Net | 33.87 | 16.74 | 10.91 |
| Other Long Term Assets Total | 46.8 | 29.49 | 30.99 |
| Note Receivable-Long Term | 20.22 | 5.37 | 12.45 |
| Total Current Assets | 839.17 | 545.36 | 390.03 |
| Capital Lease Obligations | 45.08 | 24.88 | 18.78 |
| Preferred Stock-Non Redeemable Net | Not available | 3.67 | 3.4 |
Fundamentals
Valuation and ratios
Valuation
Price to Sale Ratio6.94
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk46.82
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 64.93 | — |
| Max Healthcare Institute | INR 1,075 | 1.05 L | 71.47 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.89 | — |
| Aster DM Healthcare | INR 844.4 | 44,157.18 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.07 | — |
Shareholding
Ownership
- Promoter
- 63.85%
- FII
- 8.78%
- MF
- 3.20%
- Other
- 24.17%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Nephrocare unit acquires dialysis center assets for PHP 30,000,000 - scanx.tradeMarket news · 4 Jun 2026, 6:16 pm
Nephrocare unit acquires dialysis center assets for PHP 30,000,000 scanx.trade
Broad-Based Technical Strength Lifts Nephrocare Health Services Ltd to 52-Week High of Rs 663 - Markets MojoMarket news · 4 Jun 2026, 11:27 am
Broad-Based Technical Strength Lifts Nephrocare Health Services Ltd to 52-Week High of Rs 663 Markets Mojo
Broad-Based Technical Strength Lifts Nephrocare Health Services Ltd to 52-Week High of Rs 670.4 - Markets MojoMarket news · 3 Jun 2026, 10:36 am
Broad-Based Technical Strength Lifts Nephrocare Health Services Ltd to 52-Week High of Rs 670.4 Markets Mojo
Nephrocare Health Services Ltd Shows Renewed Momentum with Technical Upgrades - Markets MojoMarket news · 3 Jun 2026, 10:22 am
Nephrocare Health Services Ltd Shows Renewed Momentum with Technical Upgrades Markets Mojo
Strong Momentum Meets Stretched Valuations as Nephrocare Health Services Ltd Reaches All-Time High - Markets MojoMarket news · 3 Jun 2026, 9:47 am
Strong Momentum Meets Stretched Valuations as Nephrocare Health Services Ltd Reaches All-Time High Markets Mojo
Nephrocare Health Services Ltd Upgraded to Hold on Technical and Financial Improvements - Markets MojoMarket news · 3 Jun 2026, 9:16 am
Nephrocare Health Services Ltd Upgraded to Hold on Technical and Financial Improvements Markets Mojo
Corporate actions
Events
- annual General MeetingAGM
- board Meetingso approve the financial results for the quarter ended June 30, 2026.
- board MeetingsAudited Results
- board MeetingsQuarterly Results
- annual General MeetingPOM
ShareKeyX Community
Discussion and sentiment for Nephrocare Health Services
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Nephrocare Health Services Limited, formerly Nephrocare Health Services Pvt Ltd, is an India-based company. The Company is primarily engaged in the business of providing dialysis and sale of related healthcare services and products. The Company offers comprehensive dialysis care through the network of clinics from diagnosis to treatment and wellness programs including hemodialysis, home and mobile dialysis, supported by a pharmacy. It has a network of approximately 490 clinics, with 43 clinics internationally across the Philippines, Uzbekistan and Nepal. Its subsidiaries include Nephrocare Health Services Central Asia FE LLC, Nephrocare Health Services International Pte. Ltd, Nephrocare Health Services Nepal Private Limited, and others.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- NEPHROPLUS
- BSE Code
- 544647
Questions
Stock FAQ
What is the symbol and ISIN of Nephrocare Health Services?
Nephrocare Health Services has the symbol NEPHROPLUS and ISIN - INE428V01029.
What is the current price of Nephrocare Health Services?
Nephrocare Health Services is currently trading at INR 713.00.
What are the year high and year low of Nephrocare Health Services?
Nephrocare Health Services has a year high of INR 769.75 and a year low of INR 445.00.
What is the market capitalization of Nephrocare Health Services?
Nephrocare Health Services has a market capitalization of INR 6,933.50 crore.
What is the P/E ratio of Nephrocare Health Services?
Nephrocare Health Services has a P/E ratio of 87.61.
What is the dividend yield of Nephrocare Health Services?
Nephrocare Health Services has a dividend yield of NA.
How is the financial performance of Nephrocare Health Services based on revenue, net income, and EPS?
Nephrocare Health Services has revenue of INR 998.85 crore, net income of INR 76.84 crore, and EPS of NA.
What is the book value of Nephrocare Health Services?
Nephrocare Health Services has a book value of NA.
What is the debt-to-equity ratio of Nephrocare Health Services?
Nephrocare Health Services has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Nephrocare Health Services?
Nephrocare Health Services has a price-to-book ratio of NA and a price-to-sales ratio of 6.94.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.